PTEN and prostate neoplasm: To begin to examine how loss of TGFß signaling drives prostate tumor progression we performed transcriptome profiling on normal wild type prostate and on tumors from mice with prostate-specific deletion of Apc, or Pten, with or without deletion of Tgfbr2.